Evidence map›Paper›PMID 35987943›Full record

Observational studyEuropean journal of pediatrics2022

Nationwide observational study of paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the Czech Republic.

Jan David, Veronika Stara, Ondrej Hradsky, Jana Tuckova, Katerina Slaba, Petr Jabandziev, Lumir Sasek, Michal Huml, Iveta Zidkova, Jan Pavlicek and 12 more

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in European journal of pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 1 country.

Jan David *Department of Paediatrics, Second Faculty of Medicine, Charles University and University Hospital Motol, V Úvalu 84, 150 06, Prague, Czech Republic. jan.david@centrum.cz.ORCID http://orcid.org/0000-0003-1131-2475
Veronika Stara *Department of Paediatrics, Second Faculty of Medicine, Charles University and University Hospital Motol, V Úvalu 84, 150 06, Prague, Czech Republic.
Ondrej Hradsky *Department of Paediatrics, Second Faculty of Medicine, Charles University and University Hospital Motol, V Úvalu 84, 150 06, Prague, Czech Republic.
Jana TuckovaDepartment of Paediatrics, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic.
Katerina SlabaDepartment of Paediatrics, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic.
Petr JabandzievDepartment of Paediatrics, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic.
Lumir SasekDepartment of Paediatrics, Faculty of Medicine, Charles University and University Hospital Plzeň, Plzeň, Czech Republic.
Michal HumlDepartment of Paediatrics, Faculty of Medicine, Charles University and University Hospital Plzeň, Plzeň, Czech Republic.
Iveta ZidkovaDepartment of Paediatrics, Faculty of Medicine, University of Ostrava and University Hospital Ostrava, Ostrava, Czech Republic.
Jan PavlicekDepartment of Paediatrics, Faculty of Medicine, University of Ostrava and University Hospital Ostrava, Ostrava, Czech Republic.
Alzbeta PalatovaDepartment of Paediatrics, Faculty of Medicine, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic.
Eva KlaskovaDepartment of Paediatrics, Faculty of Medicine, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic.
Karina BanszkaDepartment of Paediatrics, Faculty of Medicine, Charles University and University Hospital Hradec Králové, Hradec Králové, Czech Republic.
Eva TerifajovaDepartment of Paediatrics, Faculty of Medicine, Charles University and University Hospital Hradec Králové, Hradec Králové, Czech Republic.
Radim VyhnanekDepartment of Paediatrics, First Faculty of Medicine, Charles University and University Thomayer Hospital, Prague, Czech Republic.
Marketa BloomfieldDepartment of Paediatrics, First Faculty of Medicine, Charles University and University Thomayer Hospital, Prague, Czech Republic.
Sarka FingerhutovaDepartment of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
Pavla DolezalovaDepartment of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
Lucie ProchazkovaDepartment of Paediatrics, Regional Bata Hospital, Zlín, Czech Republic.
Gabriela ChramostovaDepartment of Paediatrics, Regional Hospital, Kolín, Czech Republic.
Filip Fencl *Department of Paediatrics, Second Faculty of Medicine, Charles University and University Hospital Motol, V Úvalu 84, 150 06, Prague, Czech Republic.
Jan Lebl *Department of Paediatrics, Second Faculty of Medicine, Charles University and University Hospital Motol, V Úvalu 84, 150 06, Prague, Czech Republic.
Charles University · CZMasaryk University · CZUniversity Hospital Olomouc · CZUniversity of Ostrava · CZCentral European Institute of Technology · CZKrajská nemocnice T. Bati · CZOblastní nemocnice Kolín · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The worldwide outbreak of the novel 2019 coronavirus disease (COVID-19) has led to recognition of a new immunopathological condition: paediatric inflammatory multisystem syndrome (PIMS-TS). The Czech Republic (CZ) suffered from one of the highest incidences of individuals who tested positive during pandemic waves. The aim of this study was to analyse epidemiological, clinical, and laboratory characteristics of all cases of paediatric inflammatory multisystem syndrome (PIMS-TS) in the Czech Republic (CZ) and their predictors of severe course. We performed a retrospective-prospective nationwide observational study based on patients hospitalised with PIMS-TS in CZ between 1 November 2020 and 31 May 2021. The anonymised data of patients were abstracted from medical record review. Using the inclusion criteria according to World Health Organization definition, 207 patients with PIMS-TS were enrolled in this study. The incidence of PIMS-TS out of all SARS-CoV-2-positive children was 0.9:1,000. The estimated delay between the occurrence of PIMS-TS and the COVID-19 pandemic wave was 3 weeks. The significant initial predictors of myocardial dysfunction included mainly cardiovascular signs (hypotension, oedema, oliguria/anuria, and prolonged capillary refill). During follow-up, most patients (98.8%) had normal cardiac function, with no residual findings. No fatal cases were reported.Conclusions: A 3-week interval in combination with incidence of COVID-19 could help increase pre-test probability of PIMS-TS during pandemic waves in the suspected cases. Although the parameters of the models do not allow one to completely divide patients into high and low risk groups, knowing the most important predictors surely could help clinical management.

Indexed as

COVID-19SARS-CoV-2ChildCzech RepublicHumansPandemicsProspective StudiesRetrospective StudiesSystemic Inflammatory Response SyndromeCOVID-19IncidenceMIS-CMyocardial dysfunctionPredictorsSevere outcome

Identifiers

PMID35987943
PMCPMC9392434
OpenAlexW4292444283

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.